Status
Conditions
Treatments
About
Patients with terminal chronic kidney disease (CRD) need renal function supplementation, namely dialysis or renal transplantation. Transplantation is the most efficient and cost-effective treatment. Early and equitable access to transplantation is a public health issue. Access to transplantation is facilitated by early and systematic information and assessment of patients for inclusion in the national waiting list for transplantation prior to the onset of dialysis, and by the development of transplantation from living donors. In France, there are wide disparities in access to national waiting list registration and transplantation. One of the causes of these inequalities in access would be the disparity in referral practices to a transplant medical and surgical team authorized to register the individual on the national waiting list.
The aim of the TRACE study is to evaluate the impact of a new regional organization promoting renal transplantation on access to renal transplantation.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
4,000 participants in 2 patient groups
Loading...
Central trial contact
Myriam PASTURAL-THAUNAT, Dr; Karine POYAU
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal